Product Verification This product (Bacteriostatic Water for Injection USP, Hospira, NDC 0409-3977-03) is manufactured by Hospira Inc., a Pfizer subsidiary, and is subject to FDA oversight and USP standards
Its unique mechanism and synergy with GLP-1 agonists position it as a powerful future tool in the hands of trained professionals
That paper is not implicated in the retractions, which is why it is cited here but it studied Nle1-AngIV analogs and did not name or test Dihexa itself
HUBERMAN: Now, there are two general categories of peptides for stimulating the release of growth hormone
One tablet daily in 500ml water
Product Features 5mg BPC-157 peptide per vial Lyophilised powder format Research grade material Sealed laboratory vial Tamper evident cap Individually batch coded For laboratory research use only Product Specification Storage Instructions Store refrigerated between 2C and 8C Keep vial sealed until use Protect from heat, moisture, and direct sunlight Handle only within suitable laboratory conditions Important Notice This product is supplied strictly for laboratory research and analytical purposes only